ES541965A0 - Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico. - Google Patents

Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico.

Info

Publication number
ES541965A0
ES541965A0 ES541965A ES541965A ES541965A0 ES 541965 A0 ES541965 A0 ES 541965A0 ES 541965 A ES541965 A ES 541965A ES 541965 A ES541965 A ES 541965A ES 541965 A0 ES541965 A0 ES 541965A0
Authority
ES
Spain
Prior art keywords
chlorobenzenosfonil
benzodioxol
chloro
carboxylic
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541965A
Other languages
English (en)
Other versions
ES8800192A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES541965A0 publication Critical patent/ES541965A0/es
Publication of ES8800192A1 publication Critical patent/ES8800192A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES541965A 1984-04-06 1985-04-03 Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico. Expired ES8800192A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH175284 1984-04-06

Publications (2)

Publication Number Publication Date
ES541965A0 true ES541965A0 (es) 1987-11-01
ES8800192A1 ES8800192A1 (es) 1987-11-01

Family

ID=4217732

Family Applications (4)

Application Number Title Priority Date Filing Date
ES541965A Expired ES8800192A1 (es) 1984-04-06 1985-04-03 Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico.
ES555599A Expired ES8800921A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ES555600A Expired ES8706662A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ES555601A Expired ES8800922A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES555599A Expired ES8800921A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ES555600A Expired ES8706662A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico
ES555601A Expired ES8800922A1 (es) 1984-04-06 1986-06-02 Procedimiento para la obtencion del antipoda levogiro y dextrogiro del racemato del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico

Country Status (11)

Country Link
EP (1) EP0158596A3 (es)
JP (1) JPS60228473A (es)
AU (1) AU4089185A (es)
DK (1) DK153285A (es)
ES (4) ES8800192A1 (es)
FI (1) FI851335L (es)
GR (1) GR850845B (es)
IL (1) IL74780A0 (es)
NO (1) NO851385L (es)
PT (1) PT80222B (es)
ZA (1) ZA852554B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0516435B1 (pt) 2004-10-29 2021-09-21 Kalypsys , Inc Composto, e composição farmacêutica
AU2006305769B2 (en) * 2005-10-25 2012-06-14 Kalypsys, Inc. Salts of modulators of PPAR and methods of treating metabolic disorders
US20080176861A1 (en) 2007-01-23 2008-07-24 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75464B (es) * 1981-04-24 1984-07-20 Ciba Geigy
ATE30722T1 (de) * 1982-10-22 1987-11-15 Ciba Geigy Ag Neue benzodioxolderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
FI851335A7 (fi) 1985-10-07
IL74780A0 (en) 1985-07-31
ES8706662A1 (es) 1987-07-01
PT80222B (en) 1987-04-13
ES8800921A1 (es) 1987-12-01
FI851335L (fi) 1985-10-07
ZA852554B (en) 1985-11-27
EP0158596A3 (de) 1986-08-13
NO851385L (no) 1985-10-07
ES555600A0 (es) 1987-07-01
DK153285A (da) 1985-10-07
DK153285D0 (da) 1985-04-03
FI851335A0 (fi) 1985-04-03
ES8800192A1 (es) 1987-11-01
EP0158596A2 (de) 1985-10-16
PT80222A (en) 1985-05-01
ES555599A0 (es) 1987-12-01
AU4089185A (en) 1985-10-10
JPS60228473A (ja) 1985-11-13
GR850845B (es) 1985-11-25
ES555601A0 (es) 1987-12-01
ES8800922A1 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
ES517066A0 (es) Procedimiento para la preparacion de derivados del acido cis, endo-2-azabiciclo (3.3.0)-octan-3-carboxilico.
ES548843A0 (es) Procedimiento para la obtencion de acido alquil-1- ciclopropil-1, 4-dihidro-4-oxo-3-quinolincarboxilico.
ES515426A0 (es) Procedimiento para la obtencion de compuestos del acido 7 b-aminotiadiazolilacetilamino-3-amoniometil-3-cefem-4-carboxilico.
ES557550A0 (es) Procedimiento para la obtencion del acido 1-ciclopropil-6-fluor-1,4-dihidro-7-(4-isopropil-1-piperazinil)-4-oxo-3-quinolincarboxilico
ES537480A0 (es) Procedimiento para la fabricacion de la reductasa del acido 2, 5-diceto-d-gluconico
ES523664A0 (es) Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico.
ES512387A0 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico".
ES515446A0 (es) Procedimiento para la obtencion de derivados del acido 1,2,5-oxadiazol-3,4-dicarboxilico.
ES541965A0 (es) Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico.
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
ES511759A0 (es) Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico.
ES521230A0 (es) Procedimiento de preparacion de derivados del acido 2-tiofen-acetico.
ES518341A0 (es) Procedimiento para la preparacion del 7-metilo-3-metileno-7-octeno-1-ilo-propionato.
ES507643A0 (es) Procedimiento para la preparacion de derivados del acido salicilico .
ES537072A0 (es) Procedimiento para la obtencion del acido 1-etil-6-fluoro-1, 4-dihidro-4-oxi-7-(1-piperacinil)3-quinolincarboxilico
ES509956A0 (es) Procedimiento para la obtencion de acido 7b-acilamido-3-cefem-4-carboxilico.
ES504324A0 (es) Procedimiento para la obtencion del acido 5-(4-clorobenzoil)-1,4-dimetil-1h-pirrol-2-acetico
ES553521A0 (es) Procedimiento para la obtencion del acido 1-ciclopropil-1,4-dihidro-4-oxo-7-(1-piperazinil)-3-quinolincarbolixo
ES548095A0 (es) Procedimiento para la obtencion del acido 1-etil-6-fluor- 1,4-dihidro-4-oxo-7-(1-piperazinil)-3-quinolincarboxilico
ES508227A0 (es) "procedimiento para la preparacion de derivados del acido etilendiamino-n,n-bis-fenilacetico".
MX8502A (es) Procedimiento para la preparacion de derivados del acido acilglutamil-diaminopimelico.
ES543210A0 (es) Procedimiento para la obtencion del acido 1-etil-6-fluoro- 1,4-dihidro-4-oxo-7-(1-piperacinil)-1,8 naftiridin-3-carbo- xilico
ES539522A0 (es) Procedimiento para la obtencion del acido 4-hidroxi-2-metil-2h-1,2-benzotiazina-1,1-dioxido-3-carboxilico
ES544300A0 (es) Procedimiento para la obtencion del acido 5-(4-fluorobenzoil-1,2,4-trimetil-3-pirrolcarboxilico
ES522155A0 (es) Procedimiento para la preparacion de derivados del acido 1,4-dihidro-1-substituido-4-oxo-3-quinolin-carboxilico.